Key result
Among 85 patients taking selective serotonin reuptake inhibitors for more than two months, only 34 (40%) underwent a bone mineral density check.
Observational (n=85)
Yes
Despite the known risk of osteoporosis associated with long-term SSRI use, bone mineral density is infrequently checked in clinical practice.
BACKGROUND: To analyze the necessity of bone densitometry for patients long-term taking selective serotonin reuptake inhibitors (SSRI) over a long period of time, which is one of the risk factors of osteoporosis. METHODS: We selected patients from 5 veterans hospitals who took SSRI for more than 2 months while taking bone densitometry on a regular basis. RESULTS: Of the 85 patients from a total of 5 veterans hospitals taking SSRI for more than two months, only 34 patients were under diagnosis and treatment measures of osteoporosis through checking each person's bone mineral density. CONCLUSIONS: It is necessary for patients taking SSRI to check bone density on a regular basis.
No takes yet. Share an insight, caveat, or question.
An et al. (2013) conducted an observational in Patients taking selective serotonin reuptake inhibitors (n=85). Selective serotonin reuptake inhibitors (SSRI) was evaluated on Bone mineral density (BMD) check at least once. Among 85 patients taking selective serotonin reuptake inhibitors for more than two months, only 34 (40%) underwent a bone mineral density check.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: